Table Of Content

Author Index ADLER, W.H. see CHOPRA, R.K. BRESNIHAN, B. see KEOGAN, M.T. ALAM, A. see CANTAGREL, A. BRIGHT, R.K. see SHEARER, M.H. ALARCON-RIQUELME, M.E., MOLLER, G. & FERNANDEZ, C. Macrophage BRITTON, S. see AYEHUNIE, S. depletion decreases IgG anti-DNA in cultures from (NZB x NZW)F1 BrOcKER, E.-B. see BECKER, J.C. spleen cells by eliminating the main source of IL-6, 220 Brown, D.L. see KEoGAN, M.T. ALLEN, P.D., JOHNSTON, D.H., MAcEY, M.G., WILLIAMS, N.S. & BRUUN, J.A. see TREURNIET, R.A. NEWLAND, A.C. Modulation of CD4 by suramin, 141 BRUNO, G. see NICOLETTI, F. ALLEN, S.J. see RILEY, E.M. BUCKLEY, C., Ivison, C., POULTER, L.W. & Rustin, M.H.A. CD23 ANAND, I.S. see Morris, K. FceRI11 expression in contact sensitivity reactions: a comparison ANDERSSON, R. see SCHAUFELBERGER, C. between aeroallergen patch test reactions in atopic dermatitis and the ANSARI, A.A. see POWELL, J.D. nickel patch test reaction in non-atopic individuals, 357 ARAKAWA, M. see TAKASHIMA, N. BurG, G. see BECKER, J.C. ARREAZA, G. see RESETOKOVA, E. BURMESTER, G.R. see HORNEFF, G. ATKINS, R.C. see KAKIZAKI, Y. ATKINS, R.C. see MCDONALD, C.F. CAceERES-DitTmaRr, G., Tapia, F.J., SANCHEZ, M.A., YAMAMURA, M.., AUCOUTURIER, P. see Rocca, A. UyeMuRA, K., MODLIN, R.L., BLoom, B.R. & Convit, J. Determina- AVRAMEAS, S. see BARBOUCHE, M.R. tion of the cytokine profile in American cutaneous leishmaniasis using AYED, K. see BARBOUCHE, M.R. the polymerase chain reaction, 500 AYEHUNIE, S., SONNERBORG, A., YEMANE-BERHAN, T., ZEWDIE, D.W.., CALLAGHAN, M. see KEOGAN, M.T. BRITTON, S. & STRANNEGARD, O. Raised levels of tumour necrosis CAMERON, J.S. see CHAN, T.M. factor-alpha and neopterin, but not interferon-alpha, in serum of CANTAGREL, A., ALAM, A., Coppin, H.L., MAZIERES, B. & DE PREVAL, HIV-1-infected patients from Ethiopia, 37 C. Clonality of T lymphocytes expanded with IL-2 from rheumatoid arthritis peripheral blood, synovial fluid and synovial membrane, 83 BAELDE, J.J. see TREURNIET, R.A. CARAYON, P. see RESETKOVA, E. BAHN, R.S. see HEUFELDER, A.E. CARRIERI, G. see TAMURA, K. BANGA, J.P. see MACHT, L.M. CayoTa, A., VUILLIER, F., ScoTT-ALGARA, D., FEUILLIE, V. & DiG- BARBACANE, R.C. see CONTI, P. HIERO, G. Differential requirements for HIV-1 replication in naive and BARBOUCHE, M.R., GUILBERT, B., MAKNI, S., GorGI, Y., AYED, K. & memory CD4 Tc ells from asymptomatic HIV-1 seropositive carriers AvRAMEAS, S. Common idiotypes expressed on human, monoclonal, and AIDS patients, 241 abnormal immunoglobulins and cryoglobulins with polyreactive CHAN, T.M., FRAMPTON, G. & CAMERON, J.S. Identification of DNA- autoantibody activities, 196 binding proteins on human umbilical vein endothelial cell plasma BARCELLINI, W. see NICOLETTI, F. membrane, 110 BECKER, J.C., SCHWINN, A., DUMMER, R., BURG, G. & BROCKER, E.-B. CHATURVEDI, P. see MUKHERIEE, R. Tumour-infiltrating lymphocytes in primary melanoma: functional CHATURVEDI, U.C. see MUKHERJEE, R. consequences of differential IL-2 receptor expression, 121 CHAU, F., LEVACHER-CLERGEOT, M., DESFoRGES, B., RICATTE, L. & BEDNARIK, D.P. see POWELL, J.D. SineT, M. Prognostic value of phenotypic alterations in blood BEGARA, I. see LUJAN, L. lymphocyte subsets in a murine retrovirus-induced immunodefi- BENGTSSON, A. see MOLLNES, T.E. ciency syndrome (MAIDS), 467 BERGUK, E.C. see TREURNIET, R.A. Cuopra, R.K., Ras, N.B.K., SCALLY, J.P., DONNENBERG, A.D., ADLER, BERMUDEZ, L.E. Differential mechanisms of intracellular killing of W.H., SAAH, A.J. & MARGOLICK, J.B. Relationship between IL-2 Mycobacterium avium and Listeria monocytogenes by activated receptor expression and proliferative responses in lymphocytes from human and murine macrophages. The role of nitric oxide, 277 HIV-1 seropositive homosexual men, 18 BERNSTEIN, K., BOLSHOUN, D., GILKESON, G., MUNNS, T. & LEFKOWITH, CHOUGNET, C. see FiEvVET, N. J.B. Detection of glomerular-binding immune elements in murine CoGneg, M. see Rocca, A. lupus using a tissue-based ELISA, 449 Co.uig, D.D.S. see LusAn, L. Bess_er, H., Sirota, L., Notti, I., DuLitzky, F. & DJALDETTI, M. Il-1f ConTI, P., PANARA, M.R., BARBACANE, R.C., BONGRAZIO, M., DEMPSEY, and I]-3-like activity in preterm infants, 320 R.A. & REALE, M. Human recombinant IL-1! receptor antagonist BEYNON, H.L.C., HASKARD, D.O., Davirs, K.A., HAROUTUNIAN, R. & (IL-1 Ra) inhibits leukotriene B4 generation from human monocyte WaALport, M.J. Combinations of low concentrations of cytokines and suspensions stimulated by lipopolysaccharide (LPS), 526 acute agonists synergize in increasing the permeability of endothelial Convit, J. see CACERES-DiTTMAR, G. monolayers, 314 Cooper, A. see LEE, M.L. BLoom, B.R. see CACERES-DITTMAR, G. Coppin, H.L. see CANTAGREL, A. BoLsHOUN, D. see BERNSTEIN, K. CorAZZA, G.R. see MANTOVANI, V. BONGRAZIO, M. see ConTI, P. CorRALL, R.J. see MACHT, L.M. BorGul, M.O. see NICOLETTI, F. Costa, C.T.K.A. DA, KHANOLKAR-YOUNG, S., ELLioTT, A.M., BoTTAzzo, G.F. see NAVARRETE, C. WasuNNA, K.M.A. & McApbam, K.P.W.J. Immunoglobulin G BountTiFF, L. see Sa’apdu, A. subclass responses to mycobacterial lipoarabinomannan in HIV- BRAGLIANI, M. see MANTOVANI, V. infected and non-infected patients with tuberculosis, 25 BRAUN, J. see SiEPER, J. COTTLER-Fox, M. see KARHUMAKI, E. Bray, D.H., Squire, 8.B., KAWANA, A., JOHNSON, M.A. & POULTER, CSERNOK, E. see Gross, W.L. L.W. Antiretroviral treatment reverses HIV-induced reduction in the CZERKINSKY, C. see QUIDING, M. expression of surface antigens on alveolar macrophages in AIDS patients, 13 DANIEL, V. see WEIMER, R. BREATHNACH, S.M. The skin immune system and psoriasis, 343 Datti, A. see Simon, H.-U. 540 Author Index Davies, K.A. see BEYNON, H.L.C. GILKESON, G. see BERNSTEIN, K. Davies, R. see McINnTosH, R.S. GOLDSTEIN, R. see KARSH, J. De Groot, C. see LINDHOUT, E. GorGl, Y. see BARBOUCHE, M.R. De Heer, E. see TREURNIET, R.A. G6TzZE, O. see MOLLNES, T.E. De PRreEVAL, C. see CANTAGREL, A. GRANSTROM, G. see QUIDING, M. DELORON, P. see Fievet, N. Grasso, S. see NICOLETTI, F. DeMETRIOU, M. see SIMON, H.-U. GRATTARD, F. see QUESNEL, A. Dempsey, R.A. see CONTI, P. GREENWOOD, B.M. see RILEY, E.M. DENNIS, J.W. see Simon, H.-U. GriFFIN, G.E. see FRIEDLAND, J.S. Denoroy, L. see Rocca, A. GROSCURTH, P. see KELLER, R. DesForGESs, B. see CHAU, F. Gross, W.L., ScHmitt, W.H. & CseERNOK, E. ANCA and associated DiGHiERO, G. see CAYOTA, A. diseases: immunodiagnostic and pathogenetic aspects, | DsaLpetTTi, M. see BESSLER, H GUILBERT, B. see BARBOUCHE, M.R. DoeEHN, C. see STEFFEN, M DoGan, A., MACDONALD, T.T. & SPENCER, J. Ontogeny and induction Hansson, G.K. see SCHAUFELBERGER, C. of adhesion molecule expression in human fetal intestine, 532 Har ey, J.B. see KARSH, J. DONNENBERG, A.D. see CHOPRA, R.K. HAROUTUNIAN, R. see BEYNON, H.L.C. D'Souza, S. & Ivanyi, J. Antigen-dependent in vitro culture of HASKARD, D.O. see BEYNON, H.L.C. protective T cells from BCG-primed mice, 68 HAUSMANN, R., ZAVAZAVA, N., STEINMANN, J. & MULLER-RUCHHOLTZ, Dusois, B. see Fievet, N. W. Interaction of papain-digested HLA class I molecules with human DULITZKY, F. see BESSLER, H alloreactive cytotoxic T lymphocytes (CTL), 183 Dummer, R. see BECKER, J.C. HEUFELDER, A.E. & BAHN, R.S. Elevated expression in situ of selectin and immunoglobulin superfamily type adhesion molecules in retro- ECHTENACHER, B. see GATTI, S ocular connective tissues from patients with Graves’ ophthalmopathy, E.uiott, A.M. see Costa, C.T.K.A. Da 381 Etson, C.J. see MACHT, L.M. HiGaIns, E.A. see Simon, H.-U. EMMRICH, F. see HORNEFF, G HIsHIDA, A. see YAMAMOTO, T. HOEDEMAEKER, PH.J. see TREURNIET, R.A. Facer, C.A. see ORAGO, A.S.S HOGASEN, K. see MOLLNES, T.E. FAGGIONI, R. see GATTI, S. HOLLIMAN, R.E. see FRIEDLAND, J.S. Fain, C. see NICOLETTI, F. HOLMGREN, J. see QUIDING, M. FEIGHERY, C. see KEOGAN, M.T. Honpba, N. see YAMAMOTO, T. FERNANDEZ, C. see ALARCON-RIQUELME, M.E. Horner, G., Sack, U., KALDEN, J.R., EMMRICH, F. & BURMESTER, FERRUA, B. see QUIDING, M G.R. Reduction of monocyte-macrophage activation markers upon FEUILLIE, V. see Cayota, A. anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and Fievet, N., CHOUGNET, C., DuBois, B. & DELORON, P. Quantification of soluble CD14 in patients with rheumatoid arthritis, 207 antibody-secreting lymphocytes that react with Pf155/RESA from Hsu, H.S. see Xu, H.R. Plasmodium falciparum: an ELISPOT assay for field studies, 63 HuGues, R.A. see MACLEAN, I.L. FINN, J.E. & MATHIESON, P.W. Molecular analysis of C3 allotypes in Huitema, M.G. see STEGEMAN, C.A. patients with nephritic factor, 410 HUTCHINSON, P. see MCDONALD, C.F FITZGERALD, M.X. see KEOGAN, M.T. FoLks, T.M. see Powe LL, J.D. Fox, C.H. see KARHUMAKI, E. IQBALL, S. see MACLEAN, I.L. FRAMPTON, G. see CHAN, T.M. Isacovics, B. see SILVERMAN, E.D FRIEDLAND, J.S., SHATTOCK, R., Remick, D.G. & GriFFIN, G.E. Isopa, K. see KITAMURA, A. IsTURIZ, M.A. see GEFFNER, J.R. Mycobacterial 65-kD heat shock protein induces release of proin- Ito, I. see KURASAWA, K. flammatory cytokines from human monocytic cells, 58 IVANYI, J. see D'Souza, S. FRIEDLAND, J.S., SHATTOCK, R.J., JoHNsON, J.D., Remick, D.G., Ivison, C. see BUCKLEY, C. HOLLIMAN, R.E. & GrirFin, G.E. Differential cytokine gene expression and secretion after phagocytosis by a human monocytic cell line of Toxoplasma gondii compared with Mycobacterium tuberculo- JEFFERIS, R. Idiotypy and idiotypic networks: a time to redefine sis, 282 concepts, 193 FRIEDMANN, P.S., STRICKLAND, I., MEMON, A.A. & JOHNSON, P.M. JEHUDA-COHEN, T. see POWELL, J.D. Early time course of recruitment of immune surveillance in human JOHNSON, J.D. see FRIEDLAND, J.S. skin after chemical provocation, 351 JOHNSON, M.A. see Bray, D.H. FRISONI, M. see MANTOVANI, V JOHNSON, P.M. see FRIEDMANN, P.S. Forre, O. see KJELDSEN-KRAGH, J JOHNSTON, D.H. see ALLEN, P.D FURUSAWA, S. see OHSAKA, A. JOLLER, P. see KELLER, R. Jones, B.M. see Lau, Y.L. GANGULY, N.K. see Morris, K. Jones, M. see LEE, M.L. GARLEPP, M.J. see KELLY, H GARRED, P. see MOLLNES, T.E. KAKIZAKI, Y., KRAFT, N. & ATKINS, R.C. Interferon-gamma stimulates GASBARRINI, G. see MANTOVANI, V the secretion of IL-1, but not of IL-6, by glomerular mesangial cells, GatTrTl, S., FAGGIONI, R., ECHTENACHER, B. & GHEzzZ1I, P. Role of §21 tumour necrosis factor and reactive oxygen intermediates in lipopoly- KALDEN, J.R. see HORNEFF, G. saccharide-induced pulmonary oedema and lethality, 456 KALLENBERG, C.G.M. see STEGEMAN, C.A. GAuDIN, O.G. see QUESNEL, A. KANIUK, A. Stc. see LorTAN, J.E. GEFFNER, J.R., TREVANI, A.S., MINNUCCI, F., PALERMO, M.S., MAu- KARHUMAKI, E., VILJANEN, M.E., COTTLER-Fox, M., RANKI, A., Fox, GERI, N. & Isturiz, M.A. Extracellular acidic pH modulates oxygen- C.H. & KRouHN, K.J.E. An improved enrichment method for dependent cytotoxic responses mediated by polymorphonuclear functionally competent, highly purified peripheral blood dendritic leucocytes and monocytes, 164 cells and its application to HIV-infected blood samples, 482 GENIN, C. see QUESNEL, A. Kars, J., HARLEY, J.B., GOLDSTEIN, R. & Lazarovits, A.I. Ro/SSA GERSHON, H. see SHAPIRO, S. inhibits the autologous mixed lymphocyte reaction, 103 GHEZZ1, P. see GaTTi, S. KAWACHI, H. see SATO, T Author Index 541 KAWACHI, H. see TAKASHIMA, N. Macut, L.M., Corra.t, R.J., BANGA, J.P. & ELson, C.J. Control of Kawana, A. see BRay, D.H. human thyroid autoantibody production in SCID mice, 390 KeaT, A.C.S. see MACLEAN, I.L. MACLEAN, I.L., IQBALL, S., Woo, P., KEaT, A.C.S., HuGHEs, R.A., Kelst, R. see KELLER, R. KINGSLEY, G.H. & KNiGHT, S.C. HLA-B27 subtypes in the spon- KELLER, R., Ketst, R., JOLLER, P. & GroscurTH, P. Mononuclear darthropathies, 214 phagocytes from human bone marrow progenitor cells; morphology, Maepa, T. see KURASAWA, K. surface phenotype, and functional properties of resting and activated Maanius, L.O. see SALLBERG, M. cells, 176 Maaro, G. see NICOLETTI, F. Ket_y, H. & Gar.Lepp, M.J. T cell receptor haplotypes in families of MAKNI, S. see BARBOUCHE, M.R. patients with insulin-dependent diabetes mellitus, 226 MANTOVANI, V., CORAZZA, G.R., BRAGLIANI, M., FRISONI, M., ZANI- KENNEDY, R.C. see SHEARER, M.H. BONI, M.G. & GASBARRINI, G. Asp57-negative HLA DQ§ chain and KEOGAN, M.T., CALLAGHAN, M., YANNI, G., MULHERIN, D., FEIGHERY, DQAI*0501 allele are essential for the onset of DQw2-positive and C., Brown, D.L., FITZGERALD, M.X. & BRESNIHAN, B. Spontaneous DQw?-negative coeliac disease, 153 in vitro production of rheumatoid factor during infectious exacerba- Marco, R. Di see Nicocetti, F. tions of cystic fibrosis: correlation with circulating immune complex MARGOLICK, J.B. see CHOPRA, R.K. levels, 462 MARUYAMA, N. see KITAMURA, A. KHAMLICHI, A.A. see Rocca, A. MATHIESON, P.W. see FINN, J.E. KHANOLKAR- YOUNG, S. see Costa, C.T.K.A. DA MAUGERI, N. see GEFFNER, J.R. Kim, H. see RESETKOVA, E. MAZIERES, B. see CANTAGREL, A. KIMPEN, J.L.L. & OGRa, P.L. T cell redistribution kinetics after McApa\, K.P.W.J. see Costa, C.T.K.A. Da secondary infection of BALB/c mice with respiratory syncytial virus, McDONALD, C.F., HUTCHINSON, P. & ATKINS, R.C. Delineation of 78 pulmonary alveolar macrophage subpopulations by flow cytometry KINGSLEY, G. see SIEPER, J. in normal subjects and in patients with lung cancer, 126 KINGSLEY, G.H. see MACLEAN, I.L. McINTOSH, R.S., WATSON, P.F., PICKERILL, A.P., Davies, R. & Kita, M. see LEE, C.J. WEETMAN, A.P. No restriction of intrathyroidal T cell receptor Vx KITAGAWA, S. see OHSAKA, A. families in the thyroid of Graves’ disease, 147 KITAMURA, A., KITAMURA, M., NAGASAWA, R., MARUYAMA, N., Memon, A.A. see FRIEDMANN, P.S. MiTaRAl, T., TAKAHASHI, T. & Isopa, K. Renal fibroblasts are MENTA, R. see NICOLETTI, F. sensitive to growth-repressing and matrix-reducing factors from MERONI, P.L. see NICOLETTI, F. activated lymphocytes, 516 MEVISSEN, M.L.C.M. see LINDHOUT, E. KITAMURA, M. see KITAMURA, A. MINNUCCI, F. see GEFFNER, J.R. KJELDSEN-KRAGH, J., QUAYLE, A.J., ViINJE, O., NATviG, J.B. & Forre, MITARAI, T. see KITAMURA, A. O. A high proportion of the V61* synovial fluid yd T cells in juvenile Miura, Y. see OHSAKA, A. rheumatoid arthritis patients express the very early activation marker MobLIn, R.L. see CACERES-DiTTMAR, G. CD69, but carry the high molecular weight isoform of the leucocyte Mounan, C. see Morris, K. common antigen (CD45RA), 202 Moga, P. see QUESNEL, A. KNIGHT, S.C. see MACLEAN, I.L. MOLLER, G. see ALARCON-RIQUELME, M.E. KoIlkE, T. see KURASAWA, K. MOLLNEs, T.E., REDL, H., HOGASEN, K., BENGTSSON, A., GARRED, P., KraFT, N. see KAKIZAKI, Y. SPEILBERG, L., LEA, T., OPPERMANN, M., GOTZE, O. & SCHLAG, G. KROHN, K.J.E. see KARHUMAKI, E. Complement activation in septic baboons detected by neoepitope- Kurasawa, K., SAKAMOTO, A., MAEDA, T., SumiDA, T., ITo, L., specific assays for C3b/iC3b/C3c, CSa and the terminal CSb-9 TomioKa, H., Yosuipa, S. & Koike, T. Short-term administration of complement complex (TCC), 295 anti-L3T4 MoAb prevents diabetes in NOD mice, 376 MoncureE, C.W. see Xu, H.R. K WEKKEBOOM, J. see LINDHOUT, E. MOontTEIL, M.A. see LorTAN, J.E. Morioka, T. see SATO, T. Morita, T. see RESETKOVA, E. LANFORD, R.E. see SHEARER, M.H. Morris, K., MOHAN, C., WaAHI, P.L., ANAND, I.S. & GANGULY, N.K. Lau, Y.L., Jones, B-M., NG, K.W. & YEUNG, C.Y. Percentile ranges for Enhancement of IL-!, IL-2 production and IL-2 receptor generation serum IgG subclass concentrations in healthy Chinese children, 337 in patients with acute rheumatic fever and active rheumatic heart LAXER, R.M. see SILVERMAN, E.D. disease; a prospective study, 429 LAZAROviITS, A.I. see KARSH, J. Moroyosul, K. see OHSAKA, A. Lea, T. see MOLLNES, T.E. Moutsopou.Los, H.M. see Routsias, J.G. Lee, C.J., YOSHIMURA, N., SHIHO, O., Kita, M. & Oa, T. Local MUKHERJEE, R., CHATURVEDI, P. & CHATURVEDI, U.C. Identification immunosuppressive therapy with monoclonal anti-T cell antibody on and purification of a receptor on macrophages for the dengue virus- renal allograft survival in the rat, 362 induced suppressor cytokine, 257 Leer, M.L., To, S.S.T., Cooper, A., JoNEs, M. & SCHRIERER, L. MULHERIN, D. see KEOGAN, M.T. Augmented lymphocyte binding to cultured endothelium in psoriasis, MULLER-RUCHHOLTZ, W. see HAUSMANN, R. 346 Munns, T. see BERNSTEIN, K. LEFKOWITH, J.B. see BERNSTEIN, K. MuRASE, N. see TAMURA, K. LEVACHER-CLERGEOT, M. see CHAU, F. LINDHOUT, E., MEvISSEN, M.L.C.M., KWEKKEBOOM, J., TAGER, J.M. & NAGASAWA, R. see KITAMURA, A. De Groot, C. Direct evidence that human follicular dendritic cells Naaase, M. see YAMAMOTO, T. (FDC) rescue germinal centre B cells from death by apoptosis, 330 NALESNIK, M.A. see TAMURA, K. Liu, Y.J. see YAMASHITA, W. NatviG, J.B. see KJELDSEN-KRAGH, J. LorTAN, J.E., KANIUK, A. Stc. & MonTEIL, M.A. Relationship of in NAVARRETE, C. & BoTTAzzo, G.F. In search of TCR restriction in vitro phagocytosis of serotype 14 Streptococcus pneumoniae to specific autoreactive T cell in human autoimmunity: why is it so elusive?, 189 class and IgG subclass antibody levels in healthy adults, 54 NEWLAND, A.C. see ALLEN, P.D. LucHT, F.R. see QUESNEL, A. No, K.W. see Lau, Y.L. LuJAN, L., BEGARA, I., Co_tizE, D.D.S. & Watt, N.J. Phenotypic NICOLETTI, F., BoRGHI, M.O., MERONI, P.L., BARCELLINI, W., FAIN, C., analysis of cells in bronchoalveolar lavage fluid and peripheral blood Marco, R. Di, MENTA, R., SCHORLEMMER, H.U., BRUNO, G., MAGRO, of maedi visna-infected sheep, 272 G. & Grasso, S. Prevention of cyclophosphamide-induced diabetes in the NOD/WEHI mouse with deoxyspergualin, 232 MacDOona_p, T.T. see DoGan, A. Nixsson, B. see PEKNA, M Macey, M.G. see ALLEN, P.D. NiLsson, L. see PEKNA, M 542 Author - Index Nitsson, U.R. see PEKNA, M. RoweE, P. see RILey, E.M. NILSSON-EKDAHL, K. see PEKNA, M. RuDEN, U. see SALLBERG, M. NisHi, S. see TAKASHIMA, N Rustin, M.H.A. see BUCKLEY, C. Noét, L.-H. see Rocca, A. NorpstrOM, I. see QUIDING, M Sa’abu, A., THOMSON, B.J., BOUNTIFF, L. & WessTER, A.D.B. Lympho- Nott, I. see BEsSLER, H tropic viruses in “common variable’ immunodeficiency—PCR analysis of lymphocyte DNA for HIV-1 and HHV-6, 50 Oara, P.L. see Kimpen, J.L.L SAAH, A.J. see CHOPRA, R.K. OuSAKA, A., KITAGAWA, S., Yuo, A., MOTOYOSHI, K., FURUSAWA, S., Sack, U. see HoRNeEFF, G. Miura, Y., TAKAKU, F. & Saito, M. Effects of granulocyte colony- SAEKI, T. see SATO, T. stimulating factor and granulocyte-macrophage colony-stimulating Saito, K., SHimizu, F., Sato, T. & O1re, T. Modulation of human factor on respiratory burst activity of neutrophils in patients with mesangial cell behaviour by extracellular matrix components—the myelodysplastic syndromes, 308 possible role of interstitial type III collagen, 510 Oirte, T. see SAITO, K Saito, M. see OHSAKA, A. Orte, T. see SATO, T SAKAMOTO, A. see KURASAWA, K. Orre, T. see TAKASHIMA, N. SAKARELLOS, C. see RoutTsias, J.G. Oxa, T. see LEE, C.J SAKARELLOS-DalItsIoTIs, M. see RoutTsias, J.G. Oo1, B.S. see YAMASHITA, W. SALLBERG, M., RuDEN, U., WAHREN, B. & MaGnius, L.O. Antigenic OpeLz, G. see WEIMER, R regions within the hepatitis C virus envelope | and non-structural OPPERMANN, M. see MOLLNES, T.E. proteins: identification of an I1gG3-restricted recognition site within Oraco, A.S.S. & Facer, C.A. Cytokine-induced inhibition of Plasmo- the envelope | protein, 489 dium falciparum erythrocytic growth in vitro, 287 SANCHEZ, M.A. see CACERES-DiTTMAR, G. SaTo, N.L. see SATO, T. PALERMO, M.S. see GEFFNER, J.R. Sato, T., KAWACHI, H., Morioka, T., TAKASHIMA, N., SAEK1, T., OITE, PANARA, M.R. see CONTI, P T., Sato, N.L., TAKEUCHI, M. & SHimizu, F. Nephrotoxic serum PEKNA, M., NILSSON, L., NILSSON-EKDAHL, K., NILSSON, U.R. & nephritis in nude rats: the roles of host immune reactions in the Nitsson, B. Evidence for iC3 generation during cardiopulmonary accelerated type, 131 bypass as the result of blood-gas interaction, 404 SATO, T. see SAITO, K. PETERSEN, J. see STEFFEN, M SCALLY, J.P. see CHOPRA, R.K. PETSCHE, D. see SILVERMAN, E.D. SCHAUFELBERGER, C., STEMME, S., ANDERSSON, R. & HANSSON, G.K. T PFLUGER, I. see STEFFEN, M. lymphocytes in giant cell arteritic lesions are polyclonal cells expres- PICKERILL, A.P. see MCINTOSH, R.S sing af type antigen receptors and VLA-1 integrin receptors, 421 PILAR, T. see SHAPIRO, S. SCHLAG, G. see MOLLNES, T.E. POULTER, L.W. see Bray, D.H. SCHMITT, W.H. see Gross, W.L. POULTER, L.W. see BUCKLEY, C. SCHORLEMMER, H.U. see NICOLETTI, F. PoweELL, J.D., BEDNARIK, D.P., FoLks, T.M., JEHUDA-COHEN, T.., SCHRIEBER, L. see LEE, M.L. VILLINGER, F., SELL, K.W. & ANsari, A.A. Inhibition of cellular SCHWINN, A. see BECKER, J.C. activation of retroviral replication by CD8* T cells derived from non- ScoTT-ALGaRA, D. see CayorTa, A. human primates, 473 SELL, K.W. see PowELL, J.D. POZZETTO, B. see QUESNEL, A SHAPIRO, S., PILAR, T. & GERSHON, H. Exposure to complement-bearing PREUD’ HomME, J.-L. see Rocca, A immune complexes enhances the in vitro sequestration of erythrocytes from young but not elderly donors, 301 QUAYLE, A.J. see KJELDSEN-KRAGH, J. SHATTOCK, R. see FRIEDLAND, J.S. QUESNEL, A., PozzeTTo, B., Moga, P., GRATTARD, F., LUCHT, F.R.., SHATTOCK, R.J. see FRIEDLAND, J.S. Touraing, J.L., GAupIN, O.G. & GENIN, C. Prognostic value of SHEARER, M.H., BRIGHT, R.K., LANForD, R.E. & KENNEDY, R.C. serum immunoglobulin A antibodies to po/ gene products during Immunization of mice with baculovirus-derived recombinant SV40 HIV-1 infection, 237 large tumour antigen induces protective tumour immunity to a lethal QuibDING, M., GRANSTROM, G., NorpsTROM, I., FERRUA, B., HOLMGREN, challenge with SV40-transformed cells, 266 J. & CZzeRKINSKy, C. High frequency of spontaneous interferon- SHIHO, O. see LEE, C.J. gamma-producing cells in human tonsils: role of local accessory cells SHIMIZU, F. see SAITO, K. and soluble factors, 157 SHIMIZU, F. see SATO, T. SHIMIZU, F. see TAKASHIMA, N. RAEDLER, A. see STEFFEN, M. S1eper, J., BRAUN, J., Wu, P. & KINGSLEY, G. T cells are responsible for Ras, N.B.K. see CHopra, R.K the enhanced synovial cellular immune response to triggering antigen RANKI, A. see KARHUMAKI, E. in reactive arthritis, 96 REALE, M. see Cont, P SILVERMAN, E.D., Isacovics, B., PETSCHE, D. & LAXER, R.M. Synovial REDL, H. see MOLLNES, T.E. fluid cells in juvenile arthritis: evidence of selective T cell migration to REINECKER, H.C. see STEFFEN, M. inflamed tissue, 90 Remick, D.G. see FRIEDLAND, J.S Simon, H.-U., HiGGins, E.A., DEMETRIOU, M., DatTi, A., SIMINOVITCH, RESETKOVA, E., ARREAZA, G., YOSHIKAWA, N., Morita, T., Kim, H., K.A. & DENNis, J.W. Defective expression of CD23 and autocrine CARAYON, P. & Vopé, R. Study of induction of activation of human growth-stimulation in Epstein-Barr virus (EBV)-transformed Bc ells peripheral blood mononuclear cells with a non-activating form of from patients with Wiskott-Aldrich syndrome (WAS), 43 anti-CD3 MoAb in autoimmune thyroid disease (AITD), 397 SIMINOVITCH, K.A. see Simon, H.-U. RIcaTTE, L. see CHAU, F. SINET, M. see CHAU, F. Ritey, E.M., Rowe, P., ALLEN, S.J. & GREENWooD, B.M. Soluble Sirota, L. see BESSLER, H. plasma IL-2 receptors and malaria, 495 SONNERBORG, A. see AYEHUNIE, S. Rocca, A., KHAMLICHI, A.A., AUCOUTURIER, P., NoéL, L.-H., SPEILBERG, L. see MOLLNES, T.E. Denoroy, L., PREUD’HOMME, J.-L. & CoGngé, M. Primary structure of SPENCER, J. see DOGAN, A. a variable region of the V,; subgroup (/SE) in light chain deposition Squire, S.B. see Bray, D.H. disease, 506 STEFFEN, M., REINECKER, H.C., PETERSEN, J., DOEHN, C., PFLUGER, I., Routsias, J.G., Tziouras, A.G., SAKARELLOS-DaitsioTis, M., SAKAREL- Voss, A. & RAEDLER, A. Differences in cytokine secretion by intestinal Los, C. & MoutsopouLos, H.M. Calreticulin synthetic peptide mononuclear cells, peripheral blood monocytes and alveolar macro- analogues: anti-peptide antibodies in autoimmune rheumatic dis- phages from HIV-infected patients, 30 eases, 437 STEGEMAN, C.A., TERVAERT, J.W. COHEN, HUITEMA, M.G. & KALLEN- Author Index BERG, C.G.M. Serum markers of T cell activation in relapses of VoLpE, R. see RESETKOVA, E. Wegener’s granulomatosis, 415 Voss, A. see STEFFEN, M. STEINMANN, J. see HAUSMANN, R. VUILLIER, F. see CAYOTA, A. STEMME, S. see SCHAUFELBERGER, C. STEVENHAGEN, A. & VAN FurTH, R. Interferon-gamma activates the Waul, P.L. see Morris, K. oxidative killing of Candida albicans by human granulocytes, 170 WaHREN, B. see SALLBERG, M. STRANNEGARD, O. see AYEHUNIE, S. WALport, M.J. see BEYNON, H.L.C. STRICKLAND, I. see FRIEDMANN, P.S. WANG, X.M. see Xu, H.R. SumIpA, T. see KURASAWA, K. Wasunna, K.M.A. see Costa, C.T.K.A. Da Watson, P.F. see McINTosH, R.S. TAGER, J.M. see LINDHOUT, E Watt, N.J. see LUJAN, L. TAKAHASHI, T. see KITAMURA, A WessTER, A.D.B. see Sa’abu, A. TAKAKU, F. see OHSAKA, A. WEETMAN, A.P. see McINTOsH, R.S. TAKASHIMA, N., KAWACHI, H., Orre, T., NisH1, S.,. ARAKAWA, M. & WEIMER, R., ZIPPERLE, S., DANIEL, V., ZIMMERMANN, R. & OPELz, G. SHimizu, F. Effect of chlorpromazine on kinetics of injected mono- Defective IL-6 secretion in HIV-infected haemophilia patients, 249 clonal antibody in MoAb-induced glomerular injury, 135 WILLIAMS, N.S. see ALLEN, P.D. TAKASHIMA, N. see SATO, T. Woo, J. see TAMURA, K. TAKEUCHI, M. see Sato, T. Woo, P. see MACLEAN, I.L. Tamura, K., Woo, J., MURASE, N., CARRIERI, G., NALESNIK, M.A. & Wu, P. see SiEPER, J. Tuomson, A.W. Suppression of autoimmune thyroid disease by FK 506: influence on thyroid-infiltrating cells, adhesion molecule ex- Xu, H.R., TAN, Y.Y., Hsu, H.S., Moncure, C.W. & WANG, X.M. pression and anti-thyroglobulin antibody production, 368 Comparative antibody response to salmonella antigens in genetically TAN, Y.Y. see Xu, H.R. resistant and susceptible mice, 73 Tapia, F.J. see CACERES-DITTMAR, G. TERVAERT, J.W. COHEN see STEGEMAN, C.A. YAMAMOTO, T., NAGASE, M., HisHipa, A. & Honpa, N. Specific THomson, A.W. see TAMURA, K. increases in urinary excretion of anti-DNA antibodies in lupus mice THOMSON, B.J. see SA’ADU, A. induced by lysozyme administration: further evidence for DNA-anti- To, S.S.T. see LEE, M.L. DNA immune complexes in the pathogenesis of nephritis, 115 TomioKa, H. see KURASAWA, K. YAMAMURA, M. see CACERES-DITTMAR, G. TOURAINE, J.L. see QUESNEL, A. YAMASHITA, W., Liu, Y.J. & Ooi, B.S. Induction of mouse monocyte Ia TREURNIET, R.A., BERGUK, E.C., BAELDE, J.J.. DE HEER, E., HOEDE- expression by a mesangial cell-derived product, 325 MAEKER, Pu.J. & BRuUN, J.A. Gender-related influences on the YANNI, G. see KEOGAN, M.T development of chronic graft-versus-host disease-induced experi- YEMANE-BERHAN, T. see AYEHUNIE, S. mental lupus nephritis, 442 YEUNG, C.Y. see Lau, Y.L. TREVANI, A.S. see GEFFNER, J.R. YOSHIDA, S. see KURASAWA, K. Tziouras, A.G. see Routsias, J.G. YOSHIKAWA, N. see RESETKOVA, E. YOSHIMURA, N. see Leg, C.J. Yuo, A. see OHSAKA, A. Uyemura, K. see CACERES-DITTMAR, G. ZANIBONI, M.G. see MANTOVANI, V. VAN FurTH, R. see STEVENHAGEN, A. ZAVAZAVA, N. see HAUSMANN, R. VILJANEN, M.E. see KARHUMAKI, E. ZEWDIE, D.W. see AYEHUNIE, S. VILLINGER, F. see POWELL, J.D ZIMMERMANN, R. see WEIMER, R. Vinye, O. see KJELDSEN-KRAGH, J. ZIPPERLE, S. see WEIMER, R. Subject Index activation antigens, 202 coeliac disease, 153 acute agonists, 314 common variable immunodeficiency, 50 acute rejection, 362 complement, 301 adhesion molecules, 351, 368, 381, 532 complement activation, 295 adult respiratory distress syndrome, 456 connective tissue, 381 aeroallergens, 357 contact allergic sensitivity, 357 ageing, 301 contact hypersensitivity, 351 AIDS, 30, 473 cryoglobulin, 196 alloreactivity, 183 CTL inhibition, 183 alveolar macrophages, 13, 30 cyclophosphamide, 232 ankylosing spondylitis, 214 cystic fibrosis, 462 anti-CD3 MoAb, 397 cytokine, 282, 500 anti-DNA antibodies, 449 cytokines, 58, 207, 287, 314 anti-DNA antibody, 115 cytoskeleton, 135 anti-L3T4 antibody, 376 cytotoxicity, 164 anti-neutrophil cytoplasmic antibody, | anti-thyroglobulin antibody, 368 dendritic cells, 482 antibody, 73 dengue virus, 257 antibody therapy, 207 deoxyspergualin, 232 antibody-secreting cells, 63 differentiation, 397 antigen presentation, 482 DNA, 110, 410 antigenic regions, 489 dominant clonality, 83 antineutrophil cytoplasmic antibodies, 415 antiretroviral therapy, 13 E-selectin, 532 apoptosis, 330 East Africa, 37 ARF/RHD, 429 ELISA, 25 arteritis, 421 ELISPOT, 63 atopic dermatitis, 357 endothelial cell, 110 autoantibodies, 220 endothelium, 314, 346 autoimmune diabetes, 232 epitopes, 489 autoimmune rheumatic diseases, 437 erythrocyte sequestration, 301 autoimmune thyroiditis, 368 Escherichia coli, 295 autoimmunity, |, 442 Ethiopia, 37 extracellular matrix, 510 B cell, 43, 330 B cell deficiencies, 249 fibroblasts, 381 B cells, 103 FK 506, 232, 368 baboon, 295 follicular dendritic cell, 330 bacteria, 176 blood~—gas interface, 404 yd T cells, 202 bronchoalveolar lavage, 78, 272 G-CSF, 308 gel culture, 510 C3, 410 genetics 73, 410 C3 activation, 295 germinal centre, 330 CSa, 295 glomeruli, 449 CD14, 207 glomerulonephritis, | CD23, 43 GM-CSF, 308 CD4, 141, 207 graft-versus-host disease, 442 CD4* lymphocytes, 237 granule proteins, | CD4S5RA, 202 granulocytes, 170 CD4SRO, 202 Graves’ disease, 147, 397 CD69, 202 Graves’ ophthalmopathy, 381 cDNA sequence, 506 calmodulin, 135 haemophilia, 249 calreticulin, 437 Hashimoto’s thyroiditis, 397 Candida albicans, 170 HCV, 489 cardiopulmonary bypass, 404 heat shock protein, 58 Cb gene, 83 HHV-6, 50 cell adhesion, 421 HIV, 25, 249, 473, 482 cell phenotype, 272 HIV-1, 18, 39, 50, 237 cell-mediated immunity reaction, 131 HIV-1! replication, 241 cell-mediated immunity, 357 HLA, 153, 226 CEM, 141 HLA and disease, 214 Chinese, 337 HLA-DR, 13, 381 chlorpromazine, 135, 456 human, 390 chronic inflammatory bowel disease, | human mesangial cell, 510 clonality, 421 human skin, 351 Subject Index humoral immune reaction, 131 MoAb, 362 hydrogen peroxide, 170 modified MTT method, 510 monoclonal antibody, 135 a, 325 monoclonal gammopathy, 196 iC3 generation, 404 monocyte, 164, 282, 325 ICAM-1, 532 monocyte/macrophage, 526 idiotype, 196 monocytes, 58, 207 IFN-y, 157 mouse typhoid, 73 IgA antibodies, 237 mucosal immune system, 30 IgG subclass, 54 murine AIDS, 467 IgG subclasses, 337 mycobacteria, 68 IL-1, 30, 157, 429, 521 Mycobacterium tuberculosis, 282 IL-1 receptor antagonist, 526 myelodysplastic syndromes, 308 IL-18, 320 myeloma, 506 IL-2, 18, 88, 157, 397, 429, 495 IL-2 receptor, 18, 121 N-acetylcysteine, 456 IL-2R, 429, 495 naive and memory CD64 T cells, 241 IL-3-LA, 320 neopterin, 37 IL-6, 30, 220, 521 nephritic factor, 410 IL-6 secretion, 249 nephrotoxic serum nephritis, 131 immune complex, 115 neutrophil, 164 immune complexes, 301, 314, 449, 462 neutrophils, 308 immunoglobulin G subclasses, 25 nitric oxide, 176, 277 immunoglobulin light chain, 506 NOD mouse, 376 immunoregulation, 390, 473 NOD/WEHI mouse, 232 immunosuppression, 495 nude rats, 131 infection, 462 infiltrating cell, 362 percentile ranges, 337 insulin-dependent diabetes mellitus, 226 peripheral blood, 467 insulitis, 376 peripheral blood mononuclear cells, 320 interferon-alpha, 37 permeability, 314 interferon-gamma, 30, 170, 176, 232, 521 Peyer’s patches, 532 interstitial type III collagen, 510 Pf155/RESA, 63 intestine, 532 pH, 164 intracellular bacteria, 277 phagocytosis, 54 intracellular killing, 170, 277 phenotypic macrophage markers, 13 irritancy, 351 phytohaemagglutinin, 18 Plasmodium falciparum, 63, 287 juvenile rheumatoid arthritis, 202 pneumococcus, 54 juvenile/paediatrics, 90 polymerase, 237 polymerase chain reaction, 153, 500 kidney cell, 325 polyreactive autoantibody, 196 kidney fibroblasts, 516 preterm infants, 320 primary melanoma, 121 L. monoc ylogenes, 277 proliferation, 43, 397, 516 Langerhans cells, 35] protective immunity, 68 leishmaniasis, 500 proteinuria, 135 lentivirus, 272 psoriasis, 346 leucocyte common antigen, 202 pulmonary alveolar macrophage, 126 leukotriene B4, 526 light chain deposition disease, 506 reactive arthritis, 96, 214 lipoarabinomannan, 25 receptor, 257 lipopolysaccharide, 456, 526 recombinant tumour antigen, 266 local treatment, 362 regulation, 196 low affinity IgE receptors, 357 relapse, 415 lupus, 449 renal fibrosis, 516 lupus nephritis, 115, 442 resistance, 73 lymphocyte, 346 respiratory syncytial virus, 78 lymphocyte markers, 90 rheumatoid arthritis, 83, 207 lymphocyte phenotypes, 429 rheumatoid factor, 462 lymphocyte subsets, 467 Ro/SSA, 103, 437 lymphocytes, 18, 141 lymphokine, 362, 516 SCID mice, 390 lysozyme, 115 self-tolerance, 376 sepsis, 295 M. avium, 277 serine esterase, 183 macrophage differentiation and activation, 176 sex, 442 macrophages, 220, 257, 277 sheep, 272 maedi, 272 SIV, 473 major histocompatibility complex, 214 soluble class I, 183 malaria, 495 soluble IL-2 receptor, 415 malariostatic effects, 287 specific binding, 257 matrix metabolism, 516 superoxide release, 308 mesangial cell, 521 suppressor cytokine, 257 546 Subject Index suramin, 141 Toxoplasma, 282 synovial fluid, 96 tuberculosis, 25, 68 synovial fluid cells, 90 tumour necrosis factor, 30, 176, 456 synthetic peptides, 63, 437, 489 tumour necrosis factor-alpha, 37 systemic lupus erythematosus, 220, 442 tumour vaccine, 266 tumour-infiltrating lymphocytes, 121 T cell activation, 183, 415 type I diabetes, 376 T cell antigen receptor, 421 T cell frequency, 96 V gene polymorphisms, 226 T cell receptor, 83, 147, 226 vasculitis, | T cell subsets, 390 VCAM-1, 532 T cells, 103, 368 virus induced tumours, 266 T lymphocyte, 421 virus suppression, 473 T lymphocytes, 78, 500 terminal complement complex, 295 wasting syndrome, 37 thyroid autoantibody, 390 Wegener’s granulomatosis, 415 tonsils, 157